Abstract
The clinical significance of vancomycin‐intermediate S. aureus (VISA) infections is intensified by its tendency to develop resistance to antimicrobials and persistent infections. The decreasing effectiveness of the antimicrobials available is now seriously compromised; thus, there is an emergent need to invent new classes of antimicrobial agents that can rapidly and efficiently eradicate infections. Fe3O4@SiO2@chitosan (CS) nanocomposites were successfully synthesized and then decorated with nisin to gain Fe3O4/SiO2/CS/nisin‐based magnetic nanostructures (Fe3O4@SiO2@CS‐NISIN). The nanomaterials were characterized comparatively via FTIR (Fourier transform infrared spectroscopy), XRD (X‐ray diffraction), FE‐SEM (field emission scanning electron microscopes), DLS (dynamic light scattering), and VSM (vibrating sample magnetometer) methods. The methyl thiazol tetrazolium (MTT) assay was performed to determine the inhibitory effects of antibacterial agents on the cell viability. The in vitro bactericidal effect of all compounds was characterized using the microdilution assay. Finally, the topical antibacterial efficacy of free nisin, Fe3O4@SiO2@CS, and Fe3O4@SiO2@CS‐NISIN nanocomposites against murine superficial wound infection models was determined. The functionalized nanocomposites were more efficient in suppressing bacterial growth in vitro and in vivo compared to the same quantities of untargeted nanocomposites. MTT results showed acceptable biocompatibility of all nanoformulations, and no substantial difference in the cell viability was recorded between treated cells and untreated control. These results suggest that Fe3O4@SiO2@CS‐NISIN nanocomposites can be served as an alternative antimicrobial agent in innovative and emerging technologies to treat a variety of staphylococcal infections.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
